News
mars 2026
-
26 March 2026FDA draft guidance on NAMs for industry, NIH’s $150 million investment, Swiss 3RCC report, PEPPER call for partner laboratories, Cell-Microgel Biohybrid Spheroids, and more
NEWS, REPORTS & POSITION STATEMENTS 1. FDA: General considerations for the use of NAMs in drug development The Food and Drug Administration (FDA) announced the availability of a draft guidance for industry. The purpose of this draft guidance is to […]
Read more -
18 March 2026Agentic AI in biomedical research, Two decades of iPSC research, Vascularizing OOC, and more
NEWS, REPORTS & POSITION STATEMENTS 1. Agentic AI and the rise of in silico team science in biomedical research Agentic artificial intelligence (AI) systems are emerging as teams of intelligent computational experts capable of rivaling human performance in labor-intensive tasks, […]
Read more -
10 March 2026AI-Ready evaluation for Antimicrobial Resistance Research, BEACON consortium, Bruker x Noetik spatial AI models, iPSC-derived multi-organ PK/PD, and more
NEWS, REPORTS & POSITION STATEMENTS 1. Global community effort to shape new AI-ready datasets and evaluations for Antimicrobial Resistance Research The Align Foundation, a nonprofit accelerating predictive biology by convening the world’s leading minds to generate and optimize the data […]
Read more -
4 March 2026NAMs Landscape in India, French LIFT Industrial Chair, VISI-ON-BRAIN doctoral network, A human mini-bladder, and more
NEWS, REPORTS & POSITION STATEMENTS 1. India: Landscape analysis on alternatives for drug development The landscape of drug development is at a historic inflection point and undergoing a transformative shift. Scientific advances in human relevant biology, coupled with a growing […]
Read more
